ω-3 Docosahexaenoic Acid (DHA) Epoxide Generation via CYP2J2 to Protect Synapti…

Mechanistic description

The hypothesis proposes that ω-3 docosahexaenoic acid (DHA) is metabolized by CYP2J2 to generate protective epoxides that shield synaptic membranes from amyloid-beta (Aβ)-induced rigidification. Evidence from planar lipid bilayer experiments demonstrates that CYP2J2-derived epoxides mitigate Aβ-induced membrane rigidity (pmid:31243156). Aβ oligomers are known to increase membrane cholesterol content by approximately 40% and expand raft domain size in cortical neurons (pmid:24503041). Supporting this mechanism, DHA supplementation in 5xFAD mouse models reduces Aβ burden and improves synaptic plasticity markers (pmid:29982765). However, critical uncertainties exist: epoxides are rapidly metabolized by soluble epoxide hydrolase (sEH) with plasma half-lives of 2-4 hours, presenting a significant pharmacokinetic challenge (pmid:31243156). Additionally, the protective membrane fluidity model has only been validated in artificial planar bilayers, not in native neuronal membranes (Skeptic critique). Furthermore, DHA supplementation activates multiple pathways—including resolvins, protectins, and maresins—making it difficult to attribute benefits specifically to CYP2J2 epoxides (pmid:29982765). Therapeutic translation may require sEH inhibition to stabilize epoxide levels; notably, EC-5026 (sEH-397) completed Phase I trials and received FDA IND clearance in 2019 for pain (EicOsis/UC Davis clinical registry), while GSK225629 completed Phase I trials for COPD and pain with demonstrated CNS penetration (GlaxoSmithKline clinical registry).

Mechanism / pathway

CYP2J2/ω-3 DHA epoxides (sEH inhibition)
→
lipidomics

Evidence for (5)

CYP2J2-derived epoxides protect against Aβ-induced membrane rigidity in planar lipid bilayer experiments

PMID:31243156
DHA supplementation in 5xFAD mice reduces Aβ burden and improves synaptic plasticity markers

PMID:29982765
Soluble Aβ oligomers increase membrane cholesterol by 40% and raft domain size in cortical neurons

PMID:24503041
EC-5026 (sEH-397) Phase I completed, FDA IND cleared 2019 for pain indication

EicOsis/UC Davis clinical registry
GSK225629 Phase I completed for COPD/pain with CNS penetration demonstrated

GlaxoSmithKline clinical registry

Evidence against (3)

Epoxides are rapidly metabolized by soluble epoxide hydrolase (sEH), with half-lives of 2-4 hours in plasma

PMID:31243156
The membrane fluidity model was tested in artificial planar bilayers, not neuronal membranes

Skeptic critique
DHA supplementation activates multiple pathways (resolvins, protectins, maresins)—benefits cannot be attributed specifically to CYP2J2 epoxides

PMID:29982765

Evidence matrix

5 supporting 3 contradicting

53% posterior support

Supporting

CYP2J2-derived epoxides protect against Aβ-induced membrane rigidity in planar lipid bilayer experiments PMID:31243156
DHA supplementation in 5xFAD mice reduces Aβ burden and improves synaptic plasticity markers PMID:29982765
Soluble Aβ oligomers increase membrane cholesterol by 40% and raft domain size in cortical neurons PMID:24503041
EC-5026 (sEH-397) Phase I completed, FDA IND cleared 2019 for pain indication EicOsis/UC Davis clinical registry
GSK225629 Phase I completed for COPD/pain with CNS penetration demonstrated GlaxoSmithKline clinical registry

Contradicting

Epoxides are rapidly metabolized by soluble epoxide hydrolase (sEH), with half-lives of 2-4 hours in plasma PMID:31243156
The membrane fluidity model was tested in artificial planar bilayers, not neuronal membranes Skeptic critique
DHA supplementation activates multiple pathways (resolvins, protectins, maresins)—benefits cannot be attributed specifically to CYP2J2 epoxides PMID:29982765

Top-ranked evidence

trust_score × relevance_score × exp(-recency_weight × recency_days / 365)

Supports · top 3

#1 paper-8585d8f03207 0.235 trust 0.50 · rel 0.50 · 72d
#2 paper-17073801 0.235 trust 0.50 · rel 0.50 · 72d
#3 paper-27866493 0.235 trust 0.50 · rel 0.50 · 72d

4 total ranked · scidex.hypotheses.evidence_ranking

Bayesian persona consensus

53% posterior support

1 signal · 1 for / 0 against · agreement 100%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.

Cite this hypothesis

Citation

etl-backfill (2026). ω-3 Docosahexaenoic Acid (DHA) Epoxide Generation via CYP2J2 to Protect Synapti…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-593b3464

BibTeX

@misc{scidex_hypothesis_h593b346,
  title        = {ω-3 Docosahexaenoic Acid (DHA) Epoxide Generation via CYP2J2 to Protect Synapti…},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-593b3464},
  note         = {SciDEX artifact hypothesis:h-593b3464}
}